Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21

Author: Waite D.C.   Jacobson E.W.   Ennis F.A.   Edelman R.   White B.   Kammer R.   Anderson C.   Kensil C.R.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.19, Iss.28, 2001-07, pp. : 3957-3967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content